Depression in neurodegenerative diseases: Common mechanisms and current treatment options

CPC Galts, LEB Bettio, DC Jewett, CC Yang… - Neuroscience & …, 2019 - Elsevier
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder and a major
cause of disability worldwide. This neurological condition is commonly associated with …

New avenues for the treatment of Huntington's disease

A Kim, K Lalonde, A Truesdell, P Gomes Welter… - International journal of …, 2021 - mdpi.com
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in
the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum …

Choosing an animal model for the study of Huntington's disease

MA Pouladi, AJ Morton, MR Hayden - Nature Reviews Neuroscience, 2013 - nature.com
Since the identification of the causative gene in Huntington's disease (HD), a number of
animal models of this disorder have been developed. A frequently asked question is: which …

Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease

GEB Wright, JA Collins, C Kay, C McDonald… - The American Journal of …, 2019 - cell.com
Huntington disease (HD) is caused by a CAG repeat expansion in the huntingtin (HTT)
gene. Although the length of this repeat is inversely correlated with age of onset (AOO), it …

Characterization of neurophysiological and behavioral changes, MRI brain volumetry and 1H MRS in zQ175 knock-in mouse model of Huntington's disease

T Heikkinen, K Lehtimäki, N Vartiainen, J Puoliväli… - PloS one, 2012 - journals.plos.org
Huntington's disease (HD) is an autosomal neurodegenerative disorder, characterized by
severe behavioral, cognitive, and motor deficits. Since the discovery of the huntingtin gene …

Cortical and striatal circuits in Huntington's disease

S Blumenstock, I Dudanova - Frontiers in neuroscience, 2020 - frontiersin.org
Huntington's disease (HD) is a hereditary neurodegenerative disorder that typically
manifests in midlife with motor, cognitive, and/or psychiatric symptoms. The disease is …

Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's …

LM Stanek, SP Sardi, B Mastis, AR Richards… - Human gene …, 2014 - liebertpub.com
Huntington's disease (HD) is a fatal autosomal dominant neurodegenerative disease
caused by an increase in the number of polyglutamine residues in the huntingtin (Htt) …

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

MS Aymerich, E Aso, MA Abellanas, RM Tolon… - Biochemical …, 2018 - Elsevier
The endocannabinoid system (ECS) exerts a modulatory effect of important functions such
as neurotransmission, glial activation, oxidative stress, or protein homeostasis …

Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility

JY Chen, EA Wang, C Cepeda… - Frontiers in neuroscience, 2013 - frontiersin.org
Dopamine (DA) plays an essential role in the control of coordinated movements. Alterations
in DA balance in the striatum lead to pathological conditions such as Parkinson's and …

Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease

C Ferrari Bardile, M Garcia-Miralles… - Proceedings of the …, 2019 - National Acad Sciences
White matter abnormalities are a nearly universal pathological feature of neurodegenerative
disorders including Huntington disease (HD). A long-held assumption is that this white …